ArticleMedicine2026
Inverse association between dietary potassium-to-sodium ratio and systemic inflammatory markers: A cross-sectional analysis of the NHANES 2021-2023 data.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic chronic inflammation (SCI) is associated with a range of noncommunicable diseases. Emerging evidence indicates that the dietary potassium-to-sodium (K/Na) ratio may predict cardiovascular and inflammatory health more accurately than potassium or sodium alone. However, its relationship with established systemic chronic inflammation markers (SCI markers) has not yet been thoroughly investigated. This study was conducted to examine the association between dietary K/Na ratio and serum concentrations of alpha-1-acid glycoprotein (AGP) and C-reactive protein (CRP), and to explore the shape of these dose-response relationships. We performed a cross-sectional analysis of 892 adults aged ≥ 20 years using data from the National Health and Nutrition Examination Survey (NHANES) 2021 to 2023. Dietary intake was assessed via two 24-hour recalls, from which individual potassium and sodium intakes were used to calculate the K/Na ratio. Serum alpha-1-acid glycoprotein (AGP) and high-sensitivity C-reactive protein (hs-CRP) were measured using standardized immunoturbidimetric assays. We applied survey-weighted multivariable linear regression models to examine adjusted associations between the continuous K/Na ratio and each inflammatory marker, controlling for age, sex, race/ethnicity, education, income, smoking, physical activity, body mass index, hypertension, diabetes, and lipid profiles. Generalized additive models (GAMs) with penalized splines were used to assess potential nonlinear dose-response relationships. Sensitivity analyses excluded participants with CRP > 10 mg/L and explored subgroup effects by sex and race/ethnicity. After full adjustment, each 1-unit increase in dietary K/Na ratio was associated with a 0.068 mg/dL decrease in AGP (SE = 0.021; P = .001) and a 0.248 decrease in ln-transformed hs-CRP (SE = 0.095; P = .009). GAM analyses revealed a significant nonlinear inverse relationship between K/Na ratio and AGP (effective degrees of freedom = 1.49; P = .007), whereas the association with ln-CRP remained linear (edf = 1.33; P = .499). Findings were consistent across sensitivity and subgroup analyses. In this nationally representative US sample, a higher dietary K/Na ratio is independently associated with lower systemic inflammation, supporting public health strategies that promote improved potassium-to-sodium balance to mitigate chronic disease risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.